Maximize Returns with AI-Powered VRTX Insights

VRTX Forecast

Bearish <—> Bullish

80% Confidence

Bullish Case: $VRTX benefits from a $4 billion buyback program and a promising cystic fibrosis market monopoly. Strong future prospects lie in its pain treatment drug, JOURNAYX.

Bearish Case: Challenges include halted therapies and high put option volume, suggesting skepticism. Rising R&D costs can pressure profits despite strategic buybacks.

Potential Outcomes: FDA approvals lift growth: 60%.
Increased competition erodes share: 50%.
R&D cost leads to profit pressure: 60%.
Market sentiment drives volatility: 70%.

May 25, 2025

Vertex Pharmaceuticals Forecast

VRTX Vertex Pharmaceuticals

Price Forecast
Future Uncertainty

4 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

9 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

20 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

36 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

49 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

See Longer Forecasts

Correlated Assets

Assets that tend to move strongly with VRTX

KRYS Krystal Biotech (0.63)

AMGN AMGEN (0.58)

XLV Health Care Select Sector SPDR (0.44)

ALC Alcon (0.44)

BMRN Registered Shares (0.43)

Uncorrelated Assets

Assets with little price relationship to VRTX

DOW Dow (0.0)

PPL PPL (-0.0)

NVAX Novavax (-0.0)

CPRI Capri (-0.0)

DEO Diageo (-0.0)

Anticorrelated Assets

Assets that tend to move strongly against VRTX

TSM Taiwan Semiconductor Manufacturing (-0.53)

VRT Vertiv (-0.55)

CEG Constellation Energy (-0.55)

VGT Vanguard Information Technology (-0.55)

WWW Wolverine World Wide (-0.58)

Become a more profitable investor with AI optimized trading strategies

Market Forecasts

Bullish / Bearish

Digital Assets / Most Accurate

Trading Strategies

Long Volatility

Short Volatility

Balanced News

Balanced News / Sources

Tech / Memes / Politics

About

About / Pricing / Forum

Contact Helium Trades

2024 © Helium Trades
Privacy Policy & Disclosure

* Disclaimer: Nothing on this website constitutes investment advice, performance data or any recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Helium Trades is not responsible in any way for the accuracy of any model predictions or price data. Any mention of a particular security and related prediction data is not a recommendation to buy or sell that security. Investments in securities involve the risk of loss. Past performance is no guarantee of future results. Helium Trades is not responsible for any of your investment decisions, you should consult a financial expert before engaging in any transaction.